NCT03539653 is a clinical trial in Critically Ill, sponsored by Kang Yan.

Who is sponsoring NCT03539653?

NCT03539653 is sponsored by Kang Yan.

What condition does NCT03539653 study?

NCT03539653 studies Critically Ill.

Is NCT03539653 still recruiting?

NCT03539653 is currently status unknown. Last updated 9 October 2018.

Last reviewed 2018-10-09 · How we verify

NCT03539653

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Gastric Antrum Ultrasonography on Early Stage of Enteral Nutrition in Critically Ill Patients.

Status unknown Last updated 9 October 2018

What this trial tests

trial in Critically Ill in 220 participants. Status unknown.

Timeline

1 May 2018

Primary endpoint
1 May 2019

1 July 2019

Quick facts

Lead sponsor	Kang Yan
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	220
Start date	1 May 2018
Primary completion	1 May 2019
Estimated completion	1 July 2019
Sites	1 location across China

Conditions studied

Critically Ill — all drugs for Critically Ill →

Sponsor

Kang Yan

Who can join

Adults 18 to 90, any sex, with Critically Ill. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the effect of Gastric Antrum Ultrasonography on Early Stage of Enteral Nutrition in Critically Ill Patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Critically Ill

Currently open trials in the same condition.

NCT07222007 — Induction Agent Choice With Early Mortality and Prognostic Outcomes in Critically Ill Patients · recruiting
NCT07143695 — Parasternal Intercostal Muscle Thickening as an Additive Weaning Criterion · NA · recruiting
NCT06473844 — Efficacy of SGLT2 Inhibitors in Adults With Sepsis · NA · recruiting
NCT05055830 — Opportunistic PK/PD Trial in Critically Ill Children (OPTIC) · recruiting
NCT05112328 — The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding · NA · recruiting

Other Kang Yan trials

Trials by the same sponsor.

NCT03971331 — The Value of Combined Critical Care Ultrasound and PAC Monitor Oriented Therapy Protocol to Patients of ARDS With ACP · NA · unknown
NCT03811730 — The Diagnosis and Treatment System of Transesophageal Echocardiography in ICU · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03539653 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kang Yan
Last refreshed: 9 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03539653.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing